Wilhelm Huisinga

24PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 07, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

|Apr 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model.

|Jan 22, 2026
Tackling High Dimensionality in QSP: Guiding Model Order Reduction With Index Analysis.

Johannes Tillil, Wilhelm Huisinga, Jane Knöchel

|Dec 15, 2025
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization.

Zrinka Duvnjak, Robin Michelet, Casper Steenholdt

|Nov 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimization.

Malin Andersson, Franz Weber, Ferdinand Weinelt

|Aug 01, 2025
Author's Reply to Helsby and Hannam: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'.

Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender

Pageof 4

Frequent Collaborators

13 joint publications

Robin Michelet

7 joint publications

Charlotte Kloft

5 joint publications

Gerd Mikus

4 joint publications

Franziska Kluwe